Novadaq Technologies (NVDQ) 16.99 $NVDQ
TauTona Group Sells Aline HA(R) to Allergan
Marketwire - Thu Apr 17, 7:30AM CDT
TauTona Group, a medical device incubator and investment fund focused on the rapid development of innovative medical products, today announced that its wholly-owned subsidiary Aline Aesthetics has completed the sale of its Aline hyaluronic acid (HA) thread technology to Allergan, Inc. The Aline HA technology is under development for use as a dermal filler.
Equities to Watch in the Health Care Sector -- Research on Novadaq Technologies, Quest Diagnostics, Cooper Cos, and AcelRx Pharma
PR Newswire - Tue Apr 15, 11:56AM CDT
The trading session on Monday, April 14, 2014 ended on a higher note as the Dow Jones Industrial Average finished at 16,173.24, up 0.91% and the NASDAQ Composite closed at 4,022.69, up 0.57%. The S&P 500 finished the session 0.82% higher at 1,830.61. The gains were broad based as all the ten sectors finished on a positive note. The S&P 500 Health Care Sector Index finished the day at 648.05, up 0.51%, while the same has declined 3.97% in the last one month. Investor-Edge has initiated coverage on the following equities: Novadaq Technologies Inc. (NASDAQ: NVDQ), Quest Diagnostics Inc. (NYSE: DGX), The Cooper Cos Inc. (NYSE: COO) and AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX). Free technical research on NVDQ, DGX, COO and ACRX can be downloaded upon signing up at:
Nasdaq stocks posting largest percentage decreases
AP - Mon Apr 07, 12:50PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Why Novadaq Tecnologies (NVDQ) Stock Hit an All-Time High, Then Plunged Today
at The Street - Fri Apr 04, 1:21PM CDT
Novadaq Technologies (NVDQ) hit an all-time high of $24.09 on Friday after Canaccord increased its target price to $26 from $23. The firm called Novadaq "the most compelling growth story in med-tech." But just before noon, the stock turned downward...
Clinical Trial Initiation, Executive Appointments, Priced Offering, FDA Clearance, and Upcoming Conferences - Analyst Notes on Cytokinetics, Quintiles, Kindred, Volcano, and Novadaq
PR Newswire - Tue Apr 01, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Cytokinetics, Inc. (NASDAQ: CYTK), Quintiles Transnational Holdings, Inc. (NYSE: Q), Kindred Healthcare, Inc. (NYSE: KND), Volcano Corporation (NASDAQ: VOLC), and Novadaq Technologies Inc. (NASDAQ: NVDQ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
NOVADAQ to Present at the 13th Annual Needham Healthcare Conference
Marketwire - Tue Mar 25, 6:02AM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that David Martin, the company's Vice President of Corporate Development & Investor Relations, will present NOVADAQ's corporate overview at the 13th Annual Needham Healthcare Conference. NOVADAQ is scheduled to present on April 8th at 4:20 pm Eastern Time at The Westin Grand Central Hotel in New York, NY.
Is This the Top for Novadaq (NVDQ)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 17, 6:29AM CDT
Is This the Top for Novadaq (NVDQ)?
Novadaq to Present at March Investor Healthcare Meetings
Marketwire - Mon Mar 03, 6:02AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that NOVADAQ's management will present the Company's corporate overview at two investor meetings in March.
NOVADAQ to Present at the 2014 RBC Capital Markets Healthcare Conference
Marketwire - Tue Feb 11, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that Dr. Arun Menawat, the company's President and Chief Executive Officer, will present NOVADAQ's corporate overview at the 2014 RBC Capital Markets Healthcare Conference. Novadaq is scheduled to present on February 26that 8:00 am Eastern Time at The New York Palace in New York, NY.
NOVADAQ Reports 2013 Fourth Quarter and Full Year Financial Results
Marketwire - Thu Feb 06, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced fourth quarter and full-year 2013 financial results. Unless otherwise indicated, all dollar amounts in this press release are expressed in United States (U.S.) dollars.
Novadaq Technologies Inc. (NVDQ) in Focus: Stock Moves 6.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 03, 7:51AM CST
Novadaq Technologies Inc. was a big mover last session, as the company saw its shares rise a little over 6% on the day.
TauTona Group Sells 'Adipose Tissue Injector' to LifeCell
Marketwire - Mon Jan 27, 8:00AM CST
TauTona Group, a medical device incubator and investment fund focused on the rapid development of innovative medical products, today announced the sale of its Adipose Tissue Injector (aTI), a single-use, hand-held adipose tissue transfer tool, to LifeCell Corporation (LifeCell). LifeCell, along with Kinetic Concepts, Inc. and Systagenix Woundcare, form one globally diversified wound care, biologics and regenerative medicine company. Fat grafting involves moving a patient's adipose tissue from one area of the body to another. The procedure is frequently used in both aesthetic and reconstructive surgery.
NOVADAQ to Release 2013 Fourth Quarter and Full Year Financial Results on February 6, 2014 - Conference Call to Follow
Marketwire - Mon Jan 27, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ: NVDQ)(TSX: NDQ), a developer of clinically relevant imaging solutions for use in surgical and outpatient wound care procedures, will announce its fourth quarter and full year 2013 financial results before the market opening on Thursday, February 6, 2014.
TauTona Group Sells Aline HA(R) to Allergan
Marketwire - Thu Apr 17, 7:30AM CDT
TauTona Group, a medical device incubator and investment fund focused on the rapid development of innovative medical products, today announced that its wholly-owned subsidiary Aline Aesthetics has completed the sale of its Aline hyaluronic acid (HA) thread technology to Allergan, Inc. The Aline HA technology is under development for use as a dermal filler.
Equities to Watch in the Health Care Sector -- Research on Novadaq Technologies, Quest Diagnostics, Cooper Cos, and AcelRx Pharma
PR Newswire - Tue Apr 15, 11:56AM CDT
The trading session on Monday, April 14, 2014 ended on a higher note as the Dow Jones Industrial Average finished at 16,173.24, up 0.91% and the NASDAQ Composite closed at 4,022.69, up 0.57%. The S&P 500 finished the session 0.82% higher at 1,830.61. The gains were broad based as all the ten sectors finished on a positive note. The S&P 500 Health Care Sector Index finished the day at 648.05, up 0.51%, while the same has declined 3.97% in the last one month. Investor-Edge has initiated coverage on the following equities: Novadaq Technologies Inc. (NASDAQ: NVDQ), Quest Diagnostics Inc. (NYSE: DGX), The Cooper Cos Inc. (NYSE: COO) and AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX). Free technical research on NVDQ, DGX, COO and ACRX can be downloaded upon signing up at:
Nasdaq stocks posting largest percentage decreases
AP - Mon Apr 07, 12:50PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Why Novadaq Tecnologies (NVDQ) Stock Hit an All-Time High, Then Plunged Today
at The Street - Fri Apr 04, 1:21PM CDT
Novadaq Technologies (NVDQ) hit an all-time high of $24.09 on Friday after Canaccord increased its target price to $26 from $23. The firm called Novadaq "the most compelling growth story in med-tech." But just before noon, the stock turned downward...
Clinical Trial Initiation, Executive Appointments, Priced Offering, FDA Clearance, and Upcoming Conferences - Analyst Notes on Cytokinetics, Quintiles, Kindred, Volcano, and Novadaq
PR Newswire - Tue Apr 01, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Cytokinetics, Inc. (NASDAQ: CYTK), Quintiles Transnational Holdings, Inc. (NYSE: Q), Kindred Healthcare, Inc. (NYSE: KND), Volcano Corporation (NASDAQ: VOLC), and Novadaq Technologies Inc. (NASDAQ: NVDQ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
NOVADAQ to Present at the 13th Annual Needham Healthcare Conference
Marketwire - Tue Mar 25, 6:02AM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that David Martin, the company's Vice President of Corporate Development & Investor Relations, will present NOVADAQ's corporate overview at the 13th Annual Needham Healthcare Conference. NOVADAQ is scheduled to present on April 8th at 4:20 pm Eastern Time at The Westin Grand Central Hotel in New York, NY. Is This the Top for Novadaq (NVDQ)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 17, 6:29AM CDT
Is This the Top for Novadaq (NVDQ)?
Novadaq to Present at March Investor Healthcare Meetings
Marketwire - Mon Mar 03, 6:02AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that NOVADAQ's management will present the Company's corporate overview at two investor meetings in March. NOVADAQ to Present at the 2014 RBC Capital Markets Healthcare Conference
Marketwire - Tue Feb 11, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced that Dr. Arun Menawat, the company's President and Chief Executive Officer, will present NOVADAQ's corporate overview at the 2014 RBC Capital Markets Healthcare Conference. Novadaq is scheduled to present on February 26that 8:00 am Eastern Time at The New York Palace in New York, NY. NOVADAQ Reports 2013 Fourth Quarter and Full Year Financial Results
Marketwire - Thu Feb 06, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ: NVDQ)(TSX: NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, today announced fourth quarter and full-year 2013 financial results. Unless otherwise indicated, all dollar amounts in this press release are expressed in United States (U.S.) dollars. Novadaq Technologies Inc. (NVDQ) in Focus: Stock Moves 6.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 03, 7:51AM CST
Novadaq Technologies Inc. was a big mover last session, as the company saw its shares rise a little over 6% on the day.
TauTona Group Sells 'Adipose Tissue Injector' to LifeCell
Marketwire - Mon Jan 27, 8:00AM CST
TauTona Group, a medical device incubator and investment fund focused on the rapid development of innovative medical products, today announced the sale of its Adipose Tissue Injector (aTI), a single-use, hand-held adipose tissue transfer tool, to LifeCell Corporation (LifeCell). LifeCell, along with Kinetic Concepts, Inc. and Systagenix Woundcare, form one globally diversified wound care, biologics and regenerative medicine company. Fat grafting involves moving a patient's adipose tissue from one area of the body to another. The procedure is frequently used in both aesthetic and reconstructive surgery.
NOVADAQ to Release 2013 Fourth Quarter and Full Year Financial Results on February 6, 2014 - Conference Call to Follow
Marketwire - Mon Jan 27, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ: NVDQ)(TSX: NDQ), a developer of clinically relevant imaging solutions for use in surgical and outpatient wound care procedures, will announce its fourth quarter and full year 2013 financial results before the market opening on Thursday, February 6, 2014. 
